Cargando…
AB125. The correlation of SRSF1 and survivin in prostate cancer
OBJECTIVE: To test the expression of serine/arginine rich splicing factor 1 (SRSF1) and survivin [poptosis inhibiting factor (survivin)] in prostate cancer organizations, and study their correlation with the pathological features of prostate cancer, thus put forward the new targets in the treatment...
Autores principales: | Xiao, Bangming, Wang, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842731/ http://dx.doi.org/10.21037/tau.2016.s125 |
Ejemplares similares
-
AB053. Labeling of prostate tumor-specific replication-selective oncolytic adenoviruses with radioactive 125I: inhibitory effects on prostate cancer cell
por: Hao, Lin, et al.
Publicado: (2017) -
AB079. Upregulation of DEPDC1B correlates with tumor progression and predicts a poor prognosis in prostate cancer
por: Cui, Feilun, et al.
Publicado: (2017) -
AB065. EP4 antagonist suppresses bone metastasis in prostate cancer
por: Xu, Song, et al.
Publicado: (2017) -
AB077. The expression and clinical significance of α-actinin-1 in prostate cancer and benign prostatic hyperplasia
por: Cao, Feng-Hong
Publicado: (2017) -
AB262. Expression of vasohibin-1 in prostate cancer and its progress research
por: Zhang, Bo, et al.
Publicado: (2016)